Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

NEURONETICS, INC.

(STIM)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 04-10-2022
3.270 USD   +5.83%
26/09Neuronetics, Inc. lanceert innovaties voor Neurostar Advanced Therapy’s eigen Trakstar-platform
CI
13/09Neuronetics, Inc. Kondigt Grand Opening van Neurostar University aan met lintknipceremonie
CI
29/08Neuronetics ontvangt FDA-goedkeuring voor D-Tect accessoireproduct
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusHerzieningenBeursproductenFonds 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiële publicatiesSectornieuws
Nieuws in andere talen op NEURONETICS, INC.
27/09Neuronetics Launches Innovations To NeuroStar Advanced Therapy's Proprietary TrakStar P..
26/09Neuronetics Launches Innovations To NeuroStar® Advanced Therapy's Proprietary TrakStar®..
26/09Neuronetics Launches Innovations To NeuroStar® Advanced Therapy's Proprietary TrakStar®..
26/09Neuronetics, Inc. Launches Innovations to Neurostar Advanced Therapy’s Proprietary..
13/09Neuronetics, Inc. Announces Grand Opening of NeuroStar® University with Ribbon-Cutting ..
13/09Neuronetics, Inc. Announces Grand Opening of Neurostar University with Ribbon-Cutting C..
29/08Neuronetics Receives FDA Clearance for D-Tect Accessory Product
29/08Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Adv..
29/08Neuronetics Announces 510(k) Clearance of D-Tect™ MT Accessory for NeuroStar® Adva..
26/08Bruce J. Shook Notifies the Board of Directors of Neuronetics, Inc. to Resign from the ..
08/08Neuronetics Files $125 Million Mixed Shelf
05/08Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/08NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
02/08Transcript : Neuronetics, Inc., Q2 2022 Earnings Call, Aug 02, 2022
02/08Neuronetics : Q2 Earnings Snapshot
02/08Earnings Flash (STIM) NEURONETICS Reports Q2 Revenue $16.3M
02/08Neuronetics : Supplemental Financial and Operating Information
02/08Neuronetics : STIM Corporate Presentation August 2022
02/08Neuronetics Reports Second Quarter 2022 Financial and Operating Results
02/08Neuronetics, Inc. Provides Earnings Guidance for the Quarter Ending September 30, 2022 ..
02/08Neuronetics : Reports Second Quarter 2022 Financial and Operating Results - Form 8-K
02/08Neuronetics, Inc. : Regulation FD Disclosure (form 8-K)
02/08Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended ..
28/07Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference
25/07Neuronetics Agrees to Supply Transcranial Magnetic Stimulation Systems to Alleviant Hea..
25/07Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
25/07Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
25/07Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
19/07Insider Sell: Neuronetics
19/07Neuronetics Gets FDA Nod for Magnetic Stimulation System to Treat Anxious Depression; S..
19/07Top Midday Gainers
19/07Neuronetics Shares Rise 14% After FDA Clearance for Anxiety Treatment
19/07Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conf..
19/07Top Premarket Gainers
19/07Neuronetics Says FDA Clears Magnetic Stimulation System to Treat Major Depressive Disor..
19/07Neuronetics Gets FDA Clearance for NeuroStar to Treat Anxious Depression
19/07NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of A..
19/07NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of A..
19/07Neurostics Inc. Receives U.S. Food and Drug Administration Clearance for Treatment of A..
18/07Neuronetics, Inc. : Termination of a Material Definitive Agreement (form 8-K)
13/07Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
13/07Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
11/07Neuronetics Says Two Medicare Administrators Expanding Access to Transcranial Magnetic ..
11/07Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroS..
11/07Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroS..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 In..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000 In..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2500 In..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Gr..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Va..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Small C..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Small C..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Small C..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E I..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000 Gr..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2500 Va..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2500 Gr..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E V..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 2000 Dy..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000 Va..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell 3000E G..
24/06Neuronetics, Inc.(NasdaqGM:STIM) dropped from Russell Microca..
21/06Cannell Capital LLC Communicates with Neuronetics Inc
27/05Neuronetics, Inc. : Submission of Matters to a Vote of Security Holders (form 8-K)
25/05Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
17/05New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Ther..
17/05New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Ther..
12/05NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
12/05Transcript : Neuronetics, Inc., Q1 2022 Earnings Call, May 12, 2022
12/05Neuronetics : Q1 Earnings Snapshot
12/05Earnings Flash (STIM) NEURONETICS Posts Q1 Revenue $14.2M, vs. Street Est of $13.5M
12/05Neuronetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
12/05Neuronetics, Inc. : Regulation FD Disclosure (form 8-K)
12/05Neuronetics Reports First Quarter 2022 Financial and Operating Results
12/05Neuronetics, Inc. Provides Earning Guidance for the Second Quarter and Full Year of 202..
12/05North American Morning Briefing: Stocks Seen -3-
11/05Neuronetics and Transformations Care Network Announce Extended Commercial Partnership
11/05Neuronetics, Inc. and Transformations Care Network Announce Extended Commercial Partner..
11/05Neuronetics Sues BrainsWay for Misleading Psychiatrists, Patients On NeuroStar Efficacy
11/05Neuronetics TMS Leadership on Display at Clinical TMS Society Annual Meeting
11/05Neuronetics TMS Leadership on Display at Clinical TMS Society Annual Meeting
11/05Neuronetics Files Federal Lawsuit Against Brainsway for Misleading Psychiatrists and Pa..
10/05Neuronetics Shares Reverse Course, Hit 52-Week Low
10/05NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of O..
10/05NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of O..
10/05Neurostar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of O..
10/05Neuronetics Gets FDA Clearance for Obsessive-Compulsive Disorder Treatment
06/05Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/05Neuronetics, Inc. : Entry into a Material Definitive Agreement, Financial Statements and E..
03/05NeuroStar Advanced Therapy for Mental Health Announces Partnership with Mental Health A..
03/05NeuroStar Advanced Therapy for Mental Health Announces Partnership with Mental Health A..
28/04Neuronetics to Report First Quarter 2022 Financial and Operating Results and Host Confe..
11/04Sector Update: Health Care Stocks Finishing With Modest Declines
11/04Sector Update: Health Care Stocks Falling on Monday With Broader Markets
11/04Greenbrook TMS and Nasdaq-listed Neuronetics Detail "Strengthened Commercial Partnershi..
11/04Greenbrook and Neuronetics Announce Strengthened Commercial Partnership to Build Awaren..
11/04Greenbrook and Neuronetics Announces Strengthened Commercial Partnership to Build Aware..
08/03Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/03NEURONETICS, INC. Management's Discussion and Analysis of Financial Condition and Resu..
08/03Transcript : Neuronetics, Inc., Q4 2021 Earnings Call, Mar 08, 2022
Volgende evenement op NEURONETICS, INC.